237 related articles for article (PubMed ID: 17961313)
1. Comparison of three commercial tests for buprenorphine screening in urine.
Leino A; Loo BM
Ann Clin Biochem; 2007 Nov; 44(Pt 6):563-5. PubMed ID: 17961313
[TBL] [Abstract][Full Text] [Related]
2. A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse.
Melanson SE; Snyder ML; Jarolim P; Flood JG
J Anal Toxicol; 2012 Apr; 36(3):201-6. PubMed ID: 22417836
[TBL] [Abstract][Full Text] [Related]
3. Urine drug screening: a valuable office procedure.
Standridge JB; Adams SM; Zotos AP
Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens.
Cirimele V; Etienne S; Villain M; Ludes B; Kintz P
Forensic Sci Int; 2004 Jul; 143(2-3):153-6. PubMed ID: 15240036
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers.
Buchan BJ; Walsh JM; Leaverton PE
J Forensic Sci; 1998 Mar; 43(2):395-9. PubMed ID: 9544550
[TBL] [Abstract][Full Text] [Related]
6. Measurement of buprenorphine in urine: immunoassay versus LC-MS/MS.
Twigger S; Fox E; Allen K
Ann Clin Biochem; 2008 May; 45(Pt 3):339. PubMed ID: 18482930
[No Abstract] [Full Text] [Related]
7. [Study on colloidal gold labeled anti-buprenorphine monoclonal antibody for rapid test kit to detect buprenorphine].
Zeng LB; Chen LK; Hu XL; Chen L; Wang XS; Zhang YR
Fa Yi Xue Za Zhi; 2006 Apr; 22(2):130-2. PubMed ID: 16850600
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine detection in hair samples by immunometric screening test: preliminary experience.
Svaizer F; Lotti A; Gottardi M; Miozzo MP
Forensic Sci Int; 2010 Mar; 196(1-3):118-20. PubMed ID: 20080369
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of buprenorphine LUCIO immunoassay versus GC-MS using urines from a workplace drug testing program.
Alves MN; Piccinotti A; Tameni S; Polettini A
J Anal Toxicol; 2013 Apr; 37(3):175-8. PubMed ID: 23408251
[TBL] [Abstract][Full Text] [Related]
10. False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride.
Birch MA; Couchman L; Pietromartire S; Karna T; Paton C; McAllister R; Marsh A; Flanagan RJ
J Anal Toxicol; 2013 May; 37(4):233-6. PubMed ID: 23471956
[TBL] [Abstract][Full Text] [Related]
11. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
Crouch DJ; Walsh JM; Cangianelli L; Quintela O
Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
Labat L; Fontaine B; Delzenne C; Doublet A; Marek MC; Tellier D; Tonneau M; Lhermitte M; Frimat P
Forensic Sci Int; 2008 Jan; 174(2-3):90-4. PubMed ID: 17418990
[TBL] [Abstract][Full Text] [Related]
13. Comparison of eight commercial on-site screening devices for drugs-of-abuse testing.
Leino A; Saarimies J; Grönholm M; Lillsunde P
Scand J Clin Lab Invest; 2001 Jul; 61(4):325-31. PubMed ID: 11465347
[TBL] [Abstract][Full Text] [Related]
14. [Determination of buprenorphine in urine].
Hegstad S; Christophersen AS; Khiabani HZ
Tidsskr Nor Laegeforen; 2008 Jan; 128(2):184-5. PubMed ID: 18202730
[TBL] [Abstract][Full Text] [Related]
15. False-positive urine opiate screening associated with fluoroquinolone use.
Zacher JL; Givone DM
Ann Pharmacother; 2004 Sep; 38(9):1525-8. PubMed ID: 15252190
[TBL] [Abstract][Full Text] [Related]
16. Office-based treatment of opiate addiction.
Heit HA; Gourlay DL
N Engl J Med; 2003 Dec; 349(26):2567-8; author reply 2567-8. PubMed ID: 14695422
[No Abstract] [Full Text] [Related]
17. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening.
George S; Braithwaite RA
Addiction; 1995 Feb; 90(2):227-32. PubMed ID: 7703816
[TBL] [Abstract][Full Text] [Related]
18. [The development and application of an immunoenzyme assay kit for the detection of compounds of the opiate family in human biological liquids].
Nikolaeva TL; Belkina EV; Bogatyreva EA; Gribkova SE; Proskurina NV; Smirnova VK; Lapenkov MI
Sud Med Ekspert; 2008; 51(6):33-6. PubMed ID: 19172894
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine detection in urine using liquid chromatography-high-resolution mass spectrometry: comparison with cloned enzyme donor immunoassay (ThermoFisher) and homogeneous enzyme immunoassay (immunalysis).
Belsey SL; Couchman L; Flanagan RJ
J Anal Toxicol; 2014 Sep; 38(7):438-43. PubMed ID: 24925983
[TBL] [Abstract][Full Text] [Related]
20. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
McCarberg BH
Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
